id	sid	eid	entity	type
amwa-432	1	1	2025	CARDINAL
amwa-432	1	2	american	NORP
amwa-432	3	1	issn 2163-5315	PERSON
amwa-432	3	2	over 800 million	CARDINAL
amwa-432	10	1	hispanic	NORP
amwa-432	12	1	2	CARDINAL
amwa-432	18	1	over 130 years	DATE
amwa-432	19	1	the nineteenth century	DATE
amwa-432	21	1	cdc	ORG
amwa-432	21	2	30	CARDINAL
amwa-432	22	1	us	GPE
amwa-432	22	2	fda	ORG
amwa-432	22	3	1938	DATE
amwa-432	22	4	1).2	CARDINAL
amwa-432	22	5	over 800 million	CARDINAL
amwa-432	25	1	up to 20%	PERCENT
amwa-432	25	2	alicia racelis	PERSON
amwa-432	25	3	phd	PERSON
amwa-432	25	4	fayetteville	GPE
amwa-432	25	5	ga science series	ORG
amwa-432	25	6	1	CARDINAL
amwa-432	25	7	fda	ORG
amwa-432	25	8	the year	DATE
amwa-432	26	1	fda	ORG
amwa-432	26	2	us food and drug administration	ORG
amwa-432	27	1	remain.3	PERSON
amwa-432	30	1	the world health organization defines	ORG
amwa-432	31	1	about 42%	PERCENT
amwa-432	31	2	1990.4,5	DATE
amwa-432	31	3	a century	DATE
amwa-432	35	1	2).4	CARDINAL
amwa-432	35	2	2023	CARDINAL
amwa-432	35	3	the american medical association	ORG
amwa-432	36	1	sarcopenic obesity	ORG
amwa-432	38	1	the past 40 years	DATE
amwa-432	41	1	•	CARDINAL
amwa-432	41	2	•	CARDINAL
amwa-432	41	3	•	CARDINAL
amwa-432	41	4	•	CARDINAL
amwa-432	41	5	•	CARDINAL
amwa-432	42	1	2	CARDINAL
amwa-432	42	2	obesity.4,5	CARDINAL
amwa-432	42	3	age ≥20 years	DATE
amwa-432	42	4	age 2-19 years	DATE
amwa-432	44	1	the united states	GPE
amwa-432	44	2	3	CARDINAL
amwa-432	45	1	hispanic	NORP
amwa-432	46	1	74%	PERCENT
amwa-432	46	2	the united states	GPE
amwa-432	46	3	cdc	ORG
amwa-432	46	4	50%	PERCENT
amwa-432	46	5	hispanic	NORP
amwa-432	46	6	45%	PERCENT
amwa-432	46	7	only 18%	PERCENT
amwa-432	46	8	19%	PERCENT
amwa-432	46	9	hispanic	NORP
amwa-432	50	1	the american academy of pediatrics recommends	ORG
amwa-432	50	2	8 years	DATE
amwa-432	50	3	individual.14	ORG
amwa-432	50	4	between 10% and 15%	PERCENT
amwa-432	50	5	2021	DATE
amwa-432	50	6	59% to 80%	PERCENT
amwa-432	50	7	5	CARDINAL
amwa-432	52	1	levels.4	PERSON
amwa-432	55	1	20%	PERCENT
amwa-432	55	2	more.16	ORG
amwa-432	56	1	the united states	GPE
amwa-432	56	2	6	CARDINAL
amwa-432	56	3	1	CARDINAL
amwa-432	60	1	2	CARDINAL
amwa-432	62	1	12 years	DATE
amwa-432	65	1	fda	ORG
amwa-432	67	1	one	CARDINAL
amwa-432	67	2	28	CARDINAL
amwa-432	68	1	75%	PERCENT
amwa-432	68	2	44%	PERCENT
amwa-432	68	3	55%	PERCENT
amwa-432	68	4	63%).18	CARDINAL
amwa-432	68	5	3	CARDINAL
amwa-432	69	1	the ninety-fifth	DATE
amwa-432	69	2	age ≥20 years	DATE
amwa-432	69	3	age 2-19 years	DATE
amwa-432	71	1	9%	PERCENT
amwa-432	71	2	25%	PERCENT
amwa-432	71	3	26%	PERCENT
amwa-432	71	4	17%17%	PERCENT
amwa-432	71	5	50%	PERCENT
amwa-432	71	6	45%	PERCENT
amwa-432	71	7	42%	PERCENT
amwa-432	71	8	0%	PERCENT
amwa-432	71	9	10%	PERCENT
amwa-432	71	10	20%	PERCENT
amwa-432	71	11	30%	PERCENT
amwa-432	71	12	40%	PERCENT
amwa-432	71	13	50%	PERCENT
amwa-432	71	14	60%	PERCENT
amwa-432	71	15	asian	NORP
amwa-432	71	16	hispanic	NORP
amwa-432	71	17	53	CARDINAL
amwa-432	72	1	6.77 cm	QUANTITY
amwa-432	72	2	3.74 cm	QUANTITY
amwa-432	72	3	2.30	CARDINAL
amwa-432	76	1	two	CARDINAL
amwa-432	77	1	4	CARDINAL
amwa-432	84	1	1	CARDINAL
amwa-432	84	2	fda	ORG
amwa-432	84	3	alli	ORG
amwa-432	84	4	60 mg	QUANTITY
amwa-432	84	5	120 mg	QUANTITY
amwa-432	84	6	55%	PERCENT
amwa-432	84	7	37	CARDINAL
amwa-432	84	8	71%	PERCENT
amwa-432	84	9	qsymia ≥12	ORG
amwa-432	84	10	3.75 mg/23 mg	QUANTITY
amwa-432	84	11	7.5 mg/46 mg	QUANTITY
amwa-432	85	1	11.25 mg/69 mg	QUANTITY
amwa-432	85	2	15	CARDINAL
amwa-432	85	3	83%	PERCENT
amwa-432	85	4	80%	PERCENT
amwa-432	85	5	70%	PERCENT
amwa-432	85	6	51	CARDINAL
amwa-432	85	7	36	CARDINAL
amwa-432	85	8	85%	PERCENT
amwa-432	85	9	mysimba	PERSON
amwa-432	85	10	eu	ORG
amwa-432	85	11	8mg/90	CARDINAL
amwa-432	85	12	cor-i	ORG
amwa-432	85	13	85%	PERCENT
amwa-432	85	14	36	CARDINAL
amwa-432	85	15	82%	PERCENT
amwa-432	85	16	cor-ii	ORG
amwa-432	85	17	85%	PERCENT
amwa-432	85	18	36	CARDINAL
amwa-432	85	19	83%	PERCENT
amwa-432	85	20	18 mg	QUANTITY
amwa-432	85	21	30	CARDINAL
amwa-432	85	22	15	CARDINAL
amwa-432	85	23	1.2 mg	QUANTITY
amwa-432	85	24	10	CARDINAL
amwa-432	85	25	7	CARDINAL
amwa-432	85	26	2.4 mg	QUANTITY
amwa-432	85	27	6	CARDINAL
amwa-432	85	28	3 mg	QUANTITY
amwa-432	85	29	78%	PERCENT
amwa-432	85	30	45	CARDINAL
amwa-432	85	31	38	CARDINAL
amwa-432	85	32	85%	PERCENT
amwa-432	85	33	wegovy ≥12	ORG
amwa-432	85	34	0.25	CARDINAL
amwa-432	85	35	0.5 mg	QUANTITY
amwa-432	85	36	1mg	QUANTITY
amwa-432	85	37	1.7mg	QUANTITY
amwa-432	85	38	2.4	CARDINAL
amwa-432	85	39	1 73%	PERCENT
amwa-432	85	40	46	CARDINAL
amwa-432	85	41	38	CARDINAL
amwa-432	85	42	75%	PERCENT
amwa-432	85	43	0.5 ml	QUANTITY
amwa-432	85	44	2.5 mg	QUANTITY
amwa-432	85	45	5 mg	QUANTITY
amwa-432	85	46	7.5 mg	QUANTITY
amwa-432	85	47	10 mg	QUANTITY
amwa-432	85	48	12.5 mg	QUANTITY
amwa-432	85	49	15	CARDINAL
amwa-432	85	50	67.5%	PERCENT
amwa-432	86	1	45	CARDINAL
amwa-432	86	2	38	CARDINAL
amwa-432	86	3	70%	PERCENT
amwa-432	86	4	cor-i	ORG
amwa-432	86	5	cor-ii	ORG
amwa-432	86	6	eu	GPE
amwa-432	86	7	european union	ORG
amwa-432	86	8	fda	ORG
amwa-432	86	9	us food and drug administration	ORG
amwa-432	86	10	1	CARDINAL
amwa-432	88	1	a decade ago	DATE
amwa-432	89	1	2	CARDINAL
amwa-432	90	1	6.1%.21	CARDINAL
amwa-432	91	1	half	CARDINAL
amwa-432	92	1	half	CARDINAL
amwa-432	92	2	168 hours	TIME
amwa-432	93	1	12.6%	PERCENT
amwa-432	93	2	5).21	DATE
amwa-432	93	3	4	CARDINAL
amwa-432	93	4	cck	ORG
amwa-432	93	5	gaba	GPE
amwa-432	94	1	4	CARDINAL
amwa-432	94	2	yy	ORG
amwa-432	94	3	sns	ORG
amwa-432	94	4	1	CARDINAL
amwa-432	95	1	20%	PERCENT
amwa-432	95	2	41%	PERCENT
amwa-432	95	3	32%	PERCENT
amwa-432	95	4	23%	PERCENT
amwa-432	95	5	57%	PERCENT
amwa-432	95	6	65%	PERCENT
amwa-432	95	7	80%	PERCENT
amwa-432	95	8	59%	PERCENT
amwa-432	95	9	68%	PERCENT
amwa-432	95	10	77%	PERCENT
amwa-432	95	11	43%	PERCENT
amwa-432	95	12	35%	PERCENT
amwa-432	95	13	5. percent	PERCENT
amwa-432	95	14	testing.17,21	CARDINAL
amwa-432	96	1	almost 40%	PERCENT
amwa-432	96	2	70%	PERCENT
amwa-432	96	3	almost 10%	PERCENT
amwa-432	96	4	62%	PERCENT
amwa-432	96	5	more than half	CARDINAL
amwa-432	96	6	6	CARDINAL
amwa-432	97	1	about a quarter	DATE
amwa-432	97	2	about 20%	PERCENT
amwa-432	101	1	2).25,26	CARDINAL
amwa-432	102	1	one	CARDINAL
amwa-432	102	2	colitis.27	GPE
amwa-432	104	1	treatment.15	ORG
amwa-432	105	1	up to two-thirds	CARDINAL
amwa-432	105	2	discontinuation.29	LOC
amwa-432	112	1	2030	DATE
amwa-432	114	1	naomi b. bishop	PERSON
amwa-432	114	2	md	GPE
amwa-432	119	1	1	CARDINAL
amwa-432	120	1	colman e. anorectics	PERSON
amwa-432	120	2	a half century	DATE
amwa-432	121	1	ann intern med.	PERSON
amwa-432	122	1	2005	DATE
amwa-432	122	2	143(5):380-385	CARDINAL
amwa-432	123	1	2	CARDINAL
amwa-432	123	2	wen x	PERSON
amwa-432	123	3	zhang b	PERSON
amwa-432	123	4	wu	PERSON
amwa-432	126	1	2022;7(1):298	CARDINAL
amwa-432	127	1	3	CARDINAL
amwa-432	128	1	16%	PERCENT
amwa-432	128	2	11%	PERCENT
amwa-432	128	3	23%	PERCENT
amwa-432	128	4	62%	PERCENT
amwa-432	128	5	57%	PERCENT
amwa-432	128	6	84%	PERCENT
amwa-432	128	7	89%	PERCENT
amwa-432	128	8	77%	PERCENT
amwa-432	128	9	38%	PERCENT
amwa-432	128	10	43%	PERCENT
amwa-432	128	11	≥≥15%	PERCENT
amwa-432	128	12	≥≥15%	PERCENT
amwa-432	128	13	≥≥15%	PERCENT
amwa-432	128	14	≥≥15%	PERCENT
amwa-432	128	15	2	CARDINAL
amwa-432	128	16	0.6	CARDINAL
amwa-432	128	17	1	CARDINAL
amwa-432	128	18	3	CARDINAL
amwa-432	128	19	3	CARDINAL
amwa-432	129	1	6. percent	PERCENT
amwa-432	129	2	≥20	GPE
amwa-432	129	3	testing.17,21	CARDINAL
amwa-432	131	1	j nucl med	PERSON
amwa-432	131	2	2024;52(1):3-7	ORG
amwa-432	131	3	4	CARDINAL
amwa-432	131	4	schwartz	GPE
amwa-432	131	5	nicklas jm	PERSON
amwa-432	131	6	gudzune ka	PERSON
amwa-432	131	7	jay m.	PERSON
amwa-432	133	1	2023	CARDINAL
amwa-432	134	1	330(20):2000-2015	CARDINAL
amwa-432	135	1	5	CARDINAL
amwa-432	135	2	lister nb	PERSON
amwa-432	135	3	baur la	PERSON
amwa-432	135	4	felix jf	PERSON
amwa-432	136	1	nat rev dis	PERSON
amwa-432	137	1	2023;9(1):24	CARDINAL
amwa-432	137	2	6	CARDINAL
amwa-432	137	3	bosy-westphal	PERSON
amwa-432	137	4	müller mj	PERSON
amwa-432	138	1	obes rev	PERSON
amwa-432	138	2	2021;22	CARDINAL
amwa-432	138	3	2	CARDINAL
amwa-432	138	4	7	CARDINAL
amwa-432	138	5	dougherty m	ORG
amwa-432	142	1	2012;20(1):147-150	CARDINAL
amwa-432	142	2	rubino f	PERSON
amwa-432	142	3	batterham	PERSON
amwa-432	142	4	koch m	PERSON
amwa-432	143	1	lancet diabetes & endocrinology commission	ORG
amwa-432	144	1	lancet	ORG
amwa-432	145	1	2023;11(4):226	CARDINAL
amwa-432	146	1	9	CARDINAL
amwa-432	146	2	tanne jh	PERSON
amwa-432	149	1	2023;381:1400	CARDINAL
amwa-432	150	1	10	CARDINAL
amwa-432	150	2	swinburn ba	PERSON
amwa-432	150	3	kraak vi	PERSON
amwa-432	152	1	lancet	ORG
amwa-432	153	1	2019;393(10173):791	CARDINAL
amwa-432	154	1	11	CARDINAL
amwa-432	157	1	december 3, 2024	DATE
amwa-432	158	1	https://www.cdc.gov/obesity/adultobesity-facts/index.html 12	ORG
amwa-432	161	1	december 3, 2024	DATE
amwa-432	163	1	johnson-mann	PERSON
amwa-432	164	1	diet, drug	ORG
amwa-432	166	1	2023;10(6):3140-3149	CARDINAL
amwa-432	167	1	14	CARDINAL
amwa-432	168	1	gaskin cj	PERSON
amwa-432	168	2	cooper k	PERSON
amwa-432	168	3	stephens ld	PERSON
amwa-432	168	4	peeters	PERSON
amwa-432	169	1	obes rev	PERSON
amwa-432	170	1	2024;25(5):e13700. 15	DATE
amwa-432	171	1	hall s	ORG
amwa-432	173	1	2024;165(11):bqae128	CARDINAL
amwa-432	174	1	16	CARDINAL
amwa-432	174	2	gudzune ka	PERSON
amwa-432	174	3	kushner	PERSON
amwa-432	176	1	2024;332(7):571-584	CARDINAL
amwa-432	177	1	17	CARDINAL
amwa-432	177	2	chakhtoura m	PERSON
amwa-432	177	3	mantzoros cs	PERSON
amwa-432	179	1	2023;58:101882	CARDINAL
amwa-432	179	2	18	CARDINAL
amwa-432	180	1	khera	PERSON
amwa-432	181	1	jama	PERSON
amwa-432	182	1	2016;315(22):2424-2434	DATE
amwa-432	183	1	19	CARDINAL
amwa-432	183	2	li	PERSON
amwa-432	183	3	2	CARDINAL
amwa-432	185	1	2024;384	CARDINAL
amwa-432	187	1	20.	CARDINAL
amwa-432	188	1	cerbone m	ORG
amwa-432	188	2	dattani mt.	GPE
amwa-432	191	1	2024;45(3):309-342	CARDINAL
amwa-432	193	1	henderson k	PERSON
amwa-432	193	2	sloan ce	PERSON
amwa-432	195	1	2024;384	CARDINAL
amwa-432	195	2	22	CARDINAL
amwa-432	196	1	jastreboff am	PERSON
amwa-432	196	2	aronne lj	PERSON
amwa-432	196	3	ahmad nn	PERSON
amwa-432	197	1	weekly	DATE
amwa-432	199	1	205	CARDINAL
amwa-432	200	1	23	CARDINAL
amwa-432	201	1	sumithran p	ORG
amwa-432	201	2	cohen rv.	PERSON
amwa-432	203	1	lancet	ORG
amwa-432	205	1	24	CARDINAL
amwa-432	206	1	dietrich mo	PERSON
amwa-432	206	2	horvath tl	ORG
amwa-432	207	1	nat rev drug discov	PERSON
amwa-432	208	1	2012;11(9):675-691	CARDINAL
amwa-432	209	1	mm	PERSON
amwa-432	209	2	ryder jr.	PERSON
amwa-432	211	1	endocrinol	PERSON
amwa-432	212	1	2019;10:883	CARDINAL
amwa-432	213	1	brown k	PERSON
amwa-432	213	2	2	CARDINAL
amwa-432	214	1	cardiovasc	ORG
amwa-432	215	1	2023;22(1):66	CARDINAL
amwa-432	216	1	27	DATE
amwa-432	217	1	jiao f	PERSON
amwa-432	217	2	hu x	PERSON
amwa-432	219	1	2023;6(1):50	CARDINAL
amwa-432	219	2	28	CARDINAL
amwa-432	220	1	skelley jw	PERSON
amwa-432	220	2	swearengin k	PERSON
amwa-432	220	3	york al	PERSON
amwa-432	220	4	glover lh	PERSON
amwa-432	221	1	1	CARDINAL
amwa-432	222	1	2003	DATE
amwa-432	223	1	2024;64(1):204-211.e4	CARDINAL
amwa-432	224	1	29	CARDINAL
amwa-432	225	1	singh	GPE
amwa-432	225	2	chandan s	ORG
amwa-432	226	1	j clin med	PERSON